Fosphenytoin in Infants and Children

J Gordon Millichap

doi:10.15844/pedneurbriefs-12-11-11

Fosphenytoin in Infants and Children

Pediatric Neurology Briefs

Volume 12 (1998): Issue 11

By: J Gordon Millichap

Open Access

|Nov 1998

Abstract

The pharmacokinetics, safety, and tolerability of fosphenytoin in children from 1 day to 16 years old and the data available from 78 patients in two multicenter studies are reviewed from the Medical College of Virginia Commonwealth University, Richmond, VA.

References

Morton LD Clinical experience with fosphenytoin in children J Child Neurol 1998 Oct 13 Suppl 1 S19 S22 10.1177/0883073898013001061 9796748
Open DOI Search in Google Scholar Back to article
O’Brien TJ Cascino GD So EL Hanna DR Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin Neurology 1998 Oct 51 4 1034 1039 10.1212/WNL.51.4.1034 9781525
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-12-11-11 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 87 - 88

Published on: Nov 1, 1998

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Fosphenytoin,

Intravenous Fluids,

Purple Glove Syndrome

© 1998 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 12 (1998): Issue 11